Global Bulimia Nervosa Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: GA79B1EF797CEN
QYResearch

Abstracts

This report focuses on the global Bulimia Nervosa Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bulimia Nervosa Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Eli Lilly
• AstraZeneca
• Allergan
• Pfizer
• Bristol-Myers Squibb
• Johnson&Johnson
• GlaxoSmithKline

Market segment by Type, the product can be split into

• Drug Treatment
• Psychological Treatment
• Nutrition Therapy
• Others

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Bulimia Nervosa Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Bulimia Nervosa Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Bulimia Nervosa Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bulimia Nervosa Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Bulimia Nervosa Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Treatment
  1.4.3 Psychological Treatment
  1.4.4 Nutrition Therapy
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Bulimia Nervosa Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Bulimia Nervosa Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Bulimia Nervosa Treatment Industry
    1.6.1.1 Bulimia Nervosa Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Bulimia Nervosa Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Bulimia Nervosa Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Bulimia Nervosa Treatment Market Perspective (2015-2026)
2.2 Bulimia Nervosa Treatment Growth Trends by Regions
  2.2.1 Bulimia Nervosa Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Bulimia Nervosa Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Bulimia Nervosa Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Bulimia Nervosa Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Bulimia Nervosa Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Bulimia Nervosa Treatment Players by Market Size
  3.1.1 Global Top Bulimia Nervosa Treatment Players by Revenue (2015-2020)
  3.1.2 Global Bulimia Nervosa Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Bulimia Nervosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bulimia Nervosa Treatment Market Concentration Ratio
  3.2.1 Global Bulimia Nervosa Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Bulimia Nervosa Treatment Revenue in 2019
3.3 Bulimia Nervosa Treatment Key Players Head office and Area Served
3.4 Key Players Bulimia Nervosa Treatment Product Solution and Service
3.5 Date of Enter into Bulimia Nervosa Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Bulimia Nervosa Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bulimia Nervosa Treatment Forecasted Market Size by Type (2021-2026)

5 BULIMIA NERVOSA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Bulimia Nervosa Treatment Market Size by Application (2015-2020)
5.2 Global Bulimia Nervosa Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Bulimia Nervosa Treatment Market Size (2015-2020)
6.2 Bulimia Nervosa Treatment Key Players in North America (2019-2020)
6.3 North America Bulimia Nervosa Treatment Market Size by Type (2015-2020)
6.4 North America Bulimia Nervosa Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Bulimia Nervosa Treatment Market Size (2015-2020)
7.2 Bulimia Nervosa Treatment Key Players in Europe (2019-2020)
7.3 Europe Bulimia Nervosa Treatment Market Size by Type (2015-2020)
7.4 Europe Bulimia Nervosa Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Bulimia Nervosa Treatment Market Size (2015-2020)
8.2 Bulimia Nervosa Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Bulimia Nervosa Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific Bulimia Nervosa Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Eli Lilly
  9.1.1 Eli Lilly Company Details
  9.1.2 Eli Lilly Business Overview and Its Total Revenue
  9.1.3 Eli Lilly Bulimia Nervosa Treatment Introduction
  9.1.4 Eli Lilly Revenue in Bulimia Nervosa Treatment Business (2015-2020))
  9.1.5 Eli Lilly Recent Development
9.2 AstraZeneca
  9.2.1 AstraZeneca Company Details
  9.2.2 AstraZeneca Business Overview and Its Total Revenue
  9.2.3 AstraZeneca Bulimia Nervosa Treatment Introduction
  9.2.4 AstraZeneca Revenue in Bulimia Nervosa Treatment Business (2015-2020)
  9.2.5 AstraZeneca Recent Development
9.3 Allergan
  9.3.1 Allergan Company Details
  9.3.2 Allergan Business Overview and Its Total Revenue
  9.3.3 Allergan Bulimia Nervosa Treatment Introduction
  9.3.4 Allergan Revenue in Bulimia Nervosa Treatment Business (2015-2020)
  9.3.5 Allergan Recent Development
9.4 Pfizer
  9.4.1 Pfizer Company Details
  9.4.2 Pfizer Business Overview and Its Total Revenue
  9.4.3 Pfizer Bulimia Nervosa Treatment Introduction
  9.4.4 Pfizer Revenue in Bulimia Nervosa Treatment Business (2015-2020)
  9.4.5 Pfizer Recent Development
9.5 Bristol-Myers Squibb
  9.5.1 Bristol-Myers Squibb Company Details
  9.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  9.5.3 Bristol-Myers Squibb Bulimia Nervosa Treatment Introduction
  9.5.4 Bristol-Myers Squibb Revenue in Bulimia Nervosa Treatment Business (2015-2020)
  9.5.5 Bristol-Myers Squibb Recent Development
9.6 Johnson&Johnson
  9.6.1 Johnson&Johnson Company Details
  9.6.2 Johnson&Johnson Business Overview and Its Total Revenue
  9.6.3 Johnson&Johnson Bulimia Nervosa Treatment Introduction
  9.6.4 Johnson&Johnson Revenue in Bulimia Nervosa Treatment Business (2015-2020)
  9.6.5 Johnson&Johnson Recent Development
9.7 GlaxoSmithKline
  9.7.1 GlaxoSmithKline Company Details
  9.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.7.3 GlaxoSmithKline Bulimia Nervosa Treatment Introduction
  9.7.4 GlaxoSmithKline Revenue in Bulimia Nervosa Treatment Business (2015-2020)
  9.7.5 GlaxoSmithKline Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Bulimia Nervosa Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Bulimia Nervosa Treatment Revenue
Table 3. Ranking of Global Top Bulimia Nervosa Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bulimia Nervosa Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Treatment
Table 6. Key Players of Psychological Treatment
Table 7. Key Players of Nutrition Therapy
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Bulimia Nervosa Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Bulimia Nervosa Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Bulimia Nervosa Treatment Players to Combat Covid-19 Impact
Table 14. Global Bulimia Nervosa Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Bulimia Nervosa Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Bulimia Nervosa Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Bulimia Nervosa Treatment Market Share by Regions (2015-2020)
Table 18. Global Bulimia Nervosa Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Bulimia Nervosa Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Bulimia Nervosa Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Bulimia Nervosa Treatment Players
Table 25. Global Bulimia Nervosa Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Bulimia Nervosa Treatment Market Share by Players (2015-2020)
Table 27. Global Top Bulimia Nervosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bulimia Nervosa Treatment as of 2019)
Table 28. Global Bulimia Nervosa Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Bulimia Nervosa Treatment Product Solution and Service
Table 31. Date of Enter into Bulimia Nervosa Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Bulimia Nervosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Bulimia Nervosa Treatment Market Size Share by Type (2015-2020)
Table 35. Global Bulimia Nervosa Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Bulimia Nervosa Treatment Market Size Share by Application (2015-2020)
Table 37. Global Bulimia Nervosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Bulimia Nervosa Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Bulimia Nervosa Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Bulimia Nervosa Treatment Market Share (2019-2020)
Table 41. North America Bulimia Nervosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Bulimia Nervosa Treatment Market Share by Type (2015-2020)
Table 43. North America Bulimia Nervosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Bulimia Nervosa Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Bulimia Nervosa Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Bulimia Nervosa Treatment Market Share (2019-2020)
Table 47. Europe Bulimia Nervosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Bulimia Nervosa Treatment Market Share by Type (2015-2020)
Table 49. Europe Bulimia Nervosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Bulimia Nervosa Treatment Market Share by Application (2015-2020)
Table 51. Asia-Pacific Key Players Bulimia Nervosa Treatment Revenue (2019-2020) (Million US$)
Table 52. Asia-Pacific Key Players Bulimia Nervosa Treatment Market Share (2019-2020)
Table 53. Asia-Pacific Bulimia Nervosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Asia-Pacific Bulimia Nervosa Treatment Market Share by Type (2015-2020)
Table 55. Asia-Pacific Bulimia Nervosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Asia-Pacific Bulimia Nervosa Treatment Market Share by Application (2015-2020)
Table 57. Eli Lilly Company Details
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Product
Table 60. Eli Lilly Revenue in Bulimia Nervosa Treatment Business (2015-2020) (Million US$)
Table 61. Eli Lilly Recent Development
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Product
Table 65. AstraZeneca Revenue in Bulimia Nervosa Treatment Business (2015-2020) (Million US$)
Table 66. AstraZeneca Recent Development
Table 67. Allergan Company Details
Table 68. Allergan Business Overview
Table 69. Allergan Product
Table 70. Allergan Revenue in Bulimia Nervosa Treatment Business (2015-2020) (Million US$)
Table 71. Allergan Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Product
Table 75. Pfizer Revenue in Bulimia Nervosa Treatment Business (2015-2020) (Million US$)
Table 76. Pfizer Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Product
Table 80. Bristol-Myers Squibb Revenue in Bulimia Nervosa Treatment Business (2015-2020) (Million US$)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Johnson&Johnson Company Details
Table 83. Johnson&Johnson Business Overview
Table 84. Johnson&Johnson Product
Table 85. Johnson&Johnson Revenue in Bulimia Nervosa Treatment Business (2015-2020) (Million US$)
Table 86. Johnson&Johnson Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Revenue in Bulimia Nervosa Treatment Business (2015-2020) (Million US$)
Table 91. GlaxoSmithKline Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Bulimia Nervosa Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drug Treatment Features
Figure 3. Psychological Treatment Features
Figure 4. Nutrition Therapy Features
Figure 5. Others Features
Figure 6. Global Bulimia Nervosa Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Bulimia Nervosa Treatment Report Years Considered
Figure 11. Global Bulimia Nervosa Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bulimia Nervosa Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Bulimia Nervosa Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bulimia Nervosa Treatment Market Share by Players in 2019
Figure 16. Global Top Bulimia Nervosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bulimia Nervosa Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bulimia Nervosa Treatment Revenue in 2019
Figure 18. North America Bulimia Nervosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bulimia Nervosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Asia-Pacific Bulimia Nervosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Eli Lilly Revenue Growth Rate in Bulimia Nervosa Treatment Business (2015-2020)
Figure 23. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AstraZeneca Revenue Growth Rate in Bulimia Nervosa Treatment Business (2015-2020)
Figure 25. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Allergan Revenue Growth Rate in Bulimia Nervosa Treatment Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Bulimia Nervosa Treatment Business (2015-2020)
Figure 29. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bristol-Myers Squibb Revenue Growth Rate in Bulimia Nervosa Treatment Business (2015-2020)
Figure 31. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson&Johnson Revenue Growth Rate in Bulimia Nervosa Treatment Business (2015-2020)
Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline Revenue Growth Rate in Bulimia Nervosa Treatment Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed